HHS Announces $47 Million in MAHA ELEVATE Awards to 15 Organizations to Test Chronic Disease Prevention Approaches in Medicare - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

HHS Awards $47 Million to 15 Organizations to Evaluate Chronic Disease Prevention Strategies for Medicare Through MAHA ELEVATE

  • By

  • Assistant Secretary for Public Affairs (ASPA)

  • November 20, 2026

Share

Objective:

Evaluate whether functional or lifestyle medical interventions, used alongside conventional care, improve care quality and reduce costs for Medicare beneficiaries.

Approach:
  • Funding and selection: CMS awarded $47 million to 15 organizations after a competitive merit review of nearly 450 applications.
  • Interventions: Projects address chronic conditions including heart failure, dementia, diabetes, obesity, and hypertension. Each proposal includes nutrition or physical activity.
  • Evaluation: CMS will measure outcomes and costs to assess effects on beneficiaries and identify approaches that may be suitable for wider implementation.
Key Findings:
  • The awards support evaluation of strategies such as dietitian coaching, community health worker assistance, remote blood-pressure monitoring, occupational therapy, fall-prevention education, and virtual lifestyle programs.
  • The announcement states that chronic disease accounts for 90% of U.S. healthcare spending.
Interpretation:

The initiative is designed to assess whether lifestyle and functional interventions can support chronic disease prevention and management while providing value for patients and taxpayers.

Limitations:
  • The announcement describes planned evaluations; it does not report intervention outcomes or cost results.
Conclusion:

CMS said it intends to issue a new Notice of Funding Opportunity in 2027 for up to 15 additional awards.

Sources:

Original Source(s)

Related Content